1. Home
  2. AUPH vs ALM Comparison

AUPH vs ALM Comparison

Compare AUPH & ALM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AUPH
  • ALM
  • Stock Information
  • Founded
  • AUPH 1993
  • ALM N/A
  • Country
  • AUPH Canada
  • ALM Canada
  • Employees
  • AUPH N/A
  • ALM N/A
  • Industry
  • AUPH Biotechnology: Pharmaceutical Preparations
  • ALM Other Metals and Minerals
  • Sector
  • AUPH Health Care
  • ALM Basic Materials
  • Exchange
  • AUPH Nasdaq
  • ALM Nasdaq
  • Market Cap
  • AUPH 1.6B
  • ALM 1.5B
  • IPO Year
  • AUPH 1999
  • ALM N/A
  • Fundamental
  • Price
  • AUPH $16.44
  • ALM $6.37
  • Analyst Decision
  • AUPH Strong Buy
  • ALM Strong Buy
  • Analyst Count
  • AUPH 3
  • ALM 2
  • Target Price
  • AUPH $17.67
  • ALM $12.00
  • AVG Volume (30 Days)
  • AUPH 2.2M
  • ALM 1.8M
  • Earning Date
  • AUPH 11-04-2025
  • ALM 11-03-2025
  • Dividend Yield
  • AUPH N/A
  • ALM N/A
  • EPS Growth
  • AUPH N/A
  • ALM N/A
  • EPS
  • AUPH 0.55
  • ALM N/A
  • Revenue
  • AUPH $265,808,000.00
  • ALM $21,591,798.00
  • Revenue This Year
  • AUPH $17.33
  • ALM $108.36
  • Revenue Next Year
  • AUPH $14.31
  • ALM $169.35
  • P/E Ratio
  • AUPH $29.89
  • ALM N/A
  • Revenue Growth
  • AUPH 20.62
  • ALM 7.50
  • 52 Week Low
  • AUPH $6.55
  • ALM $0.89
  • 52 Week High
  • AUPH $16.47
  • ALM $10.68
  • Technical
  • Relative Strength Index (RSI)
  • AUPH 75.78
  • ALM 47.96
  • Support Level
  • AUPH $14.94
  • ALM $5.44
  • Resistance Level
  • AUPH $15.81
  • ALM $6.55
  • Average True Range (ATR)
  • AUPH 0.61
  • ALM 0.47
  • MACD
  • AUPH 0.06
  • ALM -0.05
  • Stochastic Oscillator
  • AUPH 97.97
  • ALM 49.09

About AUPH Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. It is also developing AUR200, a dual inhibitor of B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), for the potential treatment of autoimmune diseases.

About ALM Almonty Industries Inc. Common Shares

Almonty Industries Inc is engaged in the mining, processing, and shipping of tungsten concentrate from its Los Santos tungsten mine located near Salamanca, Spain - the Los Santos Mine, the processing and shipping of tungsten concentrate from its Panasqueira tin and tungsten mine in Covilha, Castelo Branco, Portugal - the Panasqueira Mine, the evaluation of its Valtreixal tin and tungsten mine project located in Western Spain in the province of Zamora - the Valtreixal Mine, as well as the exploration and evaluation of its Sangdong tungsten mine project located in Gangwon Province, Republic of Korea - the Sangdong Mine.

Share on Social Networks: